Evaluation of the Adequacy of Levothyroxine Replacement Therapy in Patients with Central Hypothyroidism1
The DOI matches its Crossref record; 33 of the 34 references it cites were found in a registry or an index.
Abstract
As there are few data on the evaluation of the adequacy of levothyroxine (l-T4) therapy in patients with central hypothyroidism (CH), a prospective study was performed to assess the accuracy of various parameters in the follow-up of 37 CH patients. Total and free thyroid hormones, TSH, and a series of clinical and biochemical indexes of peripheral thyroid hormone action have been evaluated off and on l-T4 therapy. Samples were taken before the daily administration of l-T4. In all patients off therapy, clinical hypothyroidism and low levels of free T4 (FT4) were observed, whereas values of FT3, total T4, and total T3 were below the normal range in 73%, 57%, and 19% of cases, respectively. Most of the indexes of thyroid hormone action were significantly modified after l-T4 withdrawal and exhibited significant correlation with free thyroid hormone levels. During l-T4 replacement therapy, 32 patients had circulating levels of FT4 and FT3 and indexes within the normal range with a mean l-T4 daily dose of 1.5 ± 0.3 μg/kg BW. Despite normal serum FT4, 3 patients had borderline high values of FT3 and a clear elevation of serum-soluble interleukin-2 receptor concentrations, suggesting overtreatment. Low or borderline low FT4/FT3 levels indicated undertreatment in 2 patients. The clinical parameters lack the required specificity for the diagnosis or follow-up of CH patients. The l-T4 daily dose should be established, taking into account the weight, the age, and the presence of other hormone deficiencies or pharmacological treatment of CH patients. In conclusion, our results indicate that the diagnosis of CH is reached at best by measuring TSH and FT4 concentrations. In the evaluation of the adequacy of l-T4 replacement therapy, both FT4 and FT3 serum levels together with some biochemical indexes of thyroid hormone action are all necessary to a more accurate disclosure of over- or undertreated patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Manifestations of CeH are similar to those of primary hypothyroidism, but they can be masked by coexistent MPHD [1, 24, 25].”
From 2018 European Thyroid Association (ETA) Guidelines on the Diagnosis and Management of Central Hypothyroidism (2018) · cites this paper as [24]
In the citing paper
“As in primary hypothyroidism [53], younger CeH patients require higher doses than the older ones [24, 25].”
From 2018 European Thyroid Association (ETA) Guidelines on the Diagnosis and Management of Central Hypothyroidism (2018) · cites this paper as [24]
In the citing paper
“Overt CeH is most frequently indicated by the combined findings of low FT4 with low or normal TSH concentrations [24, 25].”
From 2018 European Thyroid Association (ETA) Guidelines on the Diagnosis and Management of Central Hypothyroidism (2018) · cites this paper as [24]
In the citing paper
“Indeed, mean L-T4 daily doses of 1.2-1.6 μg/kg bw/day were judged sufficient in the large majority of adult CeH patients, with the main aim of achieving a more appropriate metabolic profile [24, 25, 55].”
From 2018 European Thyroid Association (ETA) Guidelines on the Diagnosis and Management of Central Hypothyroidism (2018) · cites this paper as [24]
In the citing paper
“In particular, serum TSH concentrations are rapidly suppressed in a large portion of CeH patients during the administration of L-T4 [24, 25].”
From 2018 European Thyroid Association (ETA) Guidelines on the Diagnosis and Management of Central Hypothyroidism (2018) · cites this paper as [24]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Mutations in PROP1 cause familial combined pituitary hormone deficiency
Wu, W., Cogan, J. D., Pfäffle, R. W., Dasen, J. S., Frisch, H., O'Connell, S. M., Flynn, S. E., Brown, M. R., Mullis, P. E., Parks, J. S., et al. (1998) · Nature Genetics · doi:10.1038/ng0298-147 · Cited by 568
Thyrotropin-Secreting Pituitary Tumors*
BECK-PECCOZ, P., BRUCKER-DAVIS, F., PERSANI, L., SMALLRIDGE, R. C., & WEINTRAUB, B. D. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-6-610 · Cited by 491
Self-citationEffects of thyroid hormones on bone and mineral metabolism
Mosekilde, L., Eriksen, E. F., & Charles, P. (1990) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30338-4 · Cited by 423
Levothyroxine Therapy in Patients with Thyroid Disease
Mandel, S. J., Brent, G. A., & Larsen, P. R. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-6-199309150-00009 · Cited by 324
Beck-Peccoz, P., Amr, S., Menezes-Ferreira, M. M., Faglia, G., & Weintraub, B. D. (1985) · New England Journal of Medicine · doi:10.1056/nejm198504253121703 · Cited by 261 · cited 1×
“Restoration and maintenance of euthyroidism represent the therapeutic goals in CH. Specific therapies, such as oral TRH administration have been abandoned because of their cost and their restricted applicability to few patients with hypothalamic hypothyroidism ( 9 , 10).”
BackgroundSelf-citationThe Variable Clinical Phenotype in Thyroid Hormone Resistance Syndrome
BECK-PECCOZ, P., & CHATTERJEE, V. K. K. (1994) · Thyroid · doi:10.1089/thy.1994.4.225 · Cited by 231
Self-citationZelissen, P. M. J., Croughs, R. J. M., van Rijk, P. P., & Raymakers, J. A. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-3-199402010-00005 · Cited by 225
Collu, R., Tang, J., Castagné, J., Lagacé, G., Masson, N., Huot, C., Deal, C., Delvin, E., Faccenda, E., Eidne, K. A., et al. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.5.3918 · Cited by 207
Wood, A. J. J., & Toft, A. D. (1994) · New England Journal of Medicine · doi:10.1056/nejm199407213310307 · Cited by 172
Hayashizaki, Y., Hiraoka, Y., Endo, Y., Miyai, K., & Matsubara, K. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08355.x · Cited by 152
Research works printed but not linked: 5
- Collu, J Clin Endocrinol Metab, 82, 1561
- Beck-Peccoz, 1988, Congenital thyroid disease., In: Bailliere Clin Endocrinol Metab, 2, 737
- Mariotti, 1992, Thyroid function and thyroid autoimmunity indipendently modulate serum concentration of soluble interleukin 2 (IL2) receptor (sIL2R) in thyroid diseases., Clin Endocrinol (Oxf), 37, 417
- Pazos, J Clin Endocrinol Metab, 80, 562
- 1988, Osteoporosis: a growing concern for the thyroidologist., Thyroid Today, 11, 1
Cited by
Items 101–157 of 157
Ravinovich, I. H., Obiols, G., Vela, E. T., Webb, S. M., Bauset, M. C., Peral, A. G., Morante, T. L., Esteban, B. M., Fernández, C. P., Pico, A. M., et al. (2007) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(07)71403-1 · Cited by 5
Diagnostic and therapeutic challenges of acquired thyrotropic deficiency
Persani, L., Bonomi, M., Radin, R., & Beck-Peccoz, P. (2012) · Annales d Endocrinologie · doi:10.1016/j.ando.2012.04.004 · Cited by 4
Self-citationЛечение первичного гипотиреоза: нерешенные вопросы
Моргунова, Т. Б., Madiyarova, M. S., & Fadeyev, V. V. (2015) · Clinical and experimental thyroidology · doi:10.14341/ket2015122-34 · Cited by 4
Dilated cardiomyopathy and rhabdomyolysis caused by hypopituitarism: a challenging diagnosis
Verhoestraete, P., Carpentier, M., Donck, J., & Vandekerckhove, H. J. (2019) · Acta cardiologica. Supplementum · doi:10.1080/00015385.2019.1665848 · Cited by 4
Endocrine Complications of Cancer Therapy
Rose, S. R., Lawson, S. A., Burns, K. C., & Merchant, T. E. (2015) · Pediatric oncology · doi:10.1007/978-3-319-16435-9_5 · Cited by 4
Lania, A. G., Giavoli, C., & Beck-Peccoz, P. (2018) · Endocrinology · doi:10.1007/978-3-319-45013-1_13 · Cited by 4
Self-citationCorrales, E. P., Castro, M. A., Ortiz-Flores, A. E., & Escobar-Morreale, H. F. (2020) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2020.09.004 · Cited by 3
Impacto do tratamento com GH sobre as funções tireoidiana e adrenal
Martins, M. R. A., & Abucham, J. (2008) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302008000500022 · Cited by 3
Zeni, D., Rissetti, G., Ongaratti, B. R., Pereira‐Lima, J. F. S., Leães, C. G. S., & Oliveira, M. C. (2019) · Endocrine Practice · doi:10.4158/ep-2018-0533 · Cited by 3
Central hypothyroidism: are patients undertreated?
Marlier, J., T'Sjoen, G. G., Kaufman, J., & Lapauw, B. (2022) · European Thyroid Journal · doi:10.1530/etj-21-0128 · Cited by 3
A prospective study on hypopituitarism after radiotherapy in non pituitary brain tumors
Bakhshandeh, M., Ordoni, J., Rakhsha, A., Azghandi, S., & Hajian, P. (2016) · Acta Medica International · doi:10.5530/ami.2016.2.16 · Cited by 3
Sh, A., Rostami, T., & Kiumarsi, A. (2014) · Iranian Journal of Blood and Cancer · Cited by 3
Pituitary Stalk Interruption Syndrome: A Case Series
Prusty, B., Sahoo, D., Das, S., Meher, D., Agarwal, V., Sahu, S. K., Choudhury, A., & Das, B. (2025) · Cureus · doi:10.7759/cureus.84437 · Cited by 2
Clinical thyroidology: beyond the 1970s’ TSH-T4 Paradigm
Lindner, H. H. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1529791 · Cited by 2
McDermott, M., & Ridgway, E. C. (2009) · CRC Press eBooks · doi:10.3109/9781420070651-5 · Cited by 2
Neuroendocrine Complications of Radiation and Cancer Therapy
Merchant, T. E., & Rose, S. R. (2013) · Medical radiology · doi:10.1007/978-3-540-75863-1_3 · Cited by 2
SECONDARY HYPOTHYROIDISM: CURRENT APPROACHES TO DIAGNOSIS AND TREATMENT
Gavrilova, T. A., Моргунова, Т. Б., & Fadeev, V. V. (2017) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2017-3-64-67 · Cited by 2
Lania, A. G., Giavoli, C., & Beck-Peccoz, P. (2016) · Endocrinology · doi:10.1007/978-3-319-29195-6_13-1 · Cited by 2
Self-citationAspects of diagnosis and treatment of hypopituitarism in adult life
Nyström, H. F. (2009) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 2
Endocrinological Changes after Subarachnoid Hemorrhage
Ferreira, M. P., Fernando, C., & Moreira, S. (2015) · Cited by 1
Comparison Among the Daily Levothyroxine Doses According to the Etiology of Hypothyroidism
Lima (2013) · Journal of Endocrinology and Metabolism · doi:10.4021/jem165w · Cited by 1
Hipopituitarismo. Panhipopituitarismo
Fernández-Rodríguez, E., Bernabeu, I., & F., C. F. (2012) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(12)70381-5 · Cited by 1
Options of Replacement Therapy in Hypothyroidism
Valentine, V., Galina, A., & Morgunov, T. (2012) · InTech eBooks · doi:10.5772/31226 · Cited by 1
Căpraru, O.-M., & Pascanu, I. M. (2014) · The Medical-Surgical Journal · Cited by 1
Disorders of the Hypothalamic–Pituitary–Thyroid Axis
Sidhaye, A. R., & Wondisford, F. E. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-375097-6.10031-9 · Cited by 1
Persani, L., Brabant, G. E., Dattani, M., Bonomi, M., Feldt‐Rasmussen, U., Fliers, E., Grüters, A., Maiter, D. M., Schoenmakers, N. A., & van Trotsenburg, A. S. P. (2019) · Yearbook of pediatric endocrinology · doi:10.1530/ey.16.3.16 · Cited by 1
Self-citationОсобливості діагностики та лікування вторинного гіпотиреозу
Maslyanko, V. A. (2021) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.15.8.2019.191690 · Cited by 1
Sidhaye, A. R. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4745-2.00018-3 · Cited by 1
Samec, B., Setnikar, G., Gaberšček, S., & Kocjan, T. (2021) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1543-8826 · Cited by 1
The Laboratory Approach to Thyroid Disorders
Sherman, S. I. (2009) · CRC Press eBooks · doi:10.3109/9781420070651-2 · Cited by 1
Persani, L. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2059-4_10 · Cited by 1
Self-citationKlawitter, B. (2006) · FreiDok plus (Universitätsbibliothek Freiburg) · Cited by 1
Ipotiroidismo centrale: diagnosi, patogenesi e terapia sostitutiva
Persani, L., Ferretti, E., Giavoli, C., & Bonomi, M. (2005) · L Endocrinologo · doi:10.1007/bf03345936
Self-citationBello, P. C., & Lara, M. T. D. J. G. (2015) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
Improving the diagnosis of central hypothyroidism
PEZZINO, V., Sipione, C., & Vigneri, R. (2008) · Journal of Endocrinological Investigation · doi:10.1007/bf03346445
Kuma, K. (2005) · Elsevier eBooks · doi:10.1016/b978-0-7216-0139-7.50010-7
Alterações endocrinológicas após hemorragia subaracnóidea
Ferreira, M. D. A., Moreira, C., & Worm, P. V. (2015) · Arquivos Brasileiros de Neurocirurgia Brazilian Neurosurgery · doi:10.1055/s-0035-1560032
Thyroid Hormone Therapy: Are Replacement Subtleties Relevant to a Patient’s Health?
Duick, D. S. (1999) · Endocrine Practice · doi:10.4158/ep.5.5.302
Substitutionstherapie mit Hormonen: Was ist gesichert?
Reschke, K., Pfeiffer, A. F. H., & Lehnert, H. (2003) · Der Internist · doi:10.1007/s00108-002-0783-6
Endocrine Consequences: Diagnostic Workout and Treatment
Giavoli, C. (2016) · Springer eBooks · doi:10.1007/978-3-319-22297-4_7
Endocrine disorders in the elderly
Yalamanchi, S., Tabatabai, L. S., & Moseley, K. F. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781107294967.029
The interaction between growth hormone and the thyroid axis
Behan, L., & Agha, A. (2010)
Diagnosi e terapia dell’ipotiroidismo centrale nella pratica quotidiana
Persani, L., Cangiano, B., Galazzi, E., & Bonomi, M. (2019) · L Endocrinologo · doi:10.1007/s40619-019-00581-6
Self-citationVasylienė, G. (2013) · Lithuanian University of Health Sciences
Lubitz, S. E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-76097-3.00020-x
(2009) · CRC Press eBooks · doi:10.1201/9781420079364.ch2
昌朋, 森., 正信, 山., & 哲郎, 佐. (2001) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.90.1805
Lania, A. G., Giavoli, C., Profka, E., & Beck-Peccoz, P. (2019) · Springer eBooks · doi:10.1007/978-3-319-72102-6_17
Self-citationPersani, L., & Bonomi, M. (2015) · Springer eBooks · doi:10.1007/978-3-319-19213-0_9
Self-citationJackson, K., Simons, Z., & Moseley, K. F. (2022) · Cambridge University Press eBooks · doi:10.1017/9781108942751.031
Shukla, P. (2024) · Journal of Immunology and Immunopathology · doi:10.5958/0973-9149.2024.00017.1
Meiser, E. (2007) · FreiDok plus (Universitätsbibliothek Freiburg)
ОСОБЕННОСТИ ДИАГНОСТИКИ И ЛЕЧЕНИЯ ВТОРИЧНОГО ГИПОТИРЕОЗА
Maslyanko, V. A. (2019) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
Rodríguez, E. F. (2012) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Metadata
- Authors
- Ferretti, E., Persani, L., Jaffrain-Rea, M.-L., Giambona, S., Tamburrano, G., & Beck-Peccoz, P.
- Affiliations
- University of L'Aquila (IT)
- University of Milan (IT)
- the Department of Experimental Medicine (E. F., M.-L.J.-R.), University of L’Aquila, L’Aquila, Italy
- Sapienza University of Rome (IT)
- Institute of Endocrine Sciences (L.P., S.G., P.B.-P.), University of Milan, Ospedale Maggiore IRCCS, Istituto Auxologico Italiano IRCCS, and Istituto Clinico Humanitas, Milan
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1999-03-01
- Volume
- 84
- Issue
- 3
- Pages
- 924-929
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2096057448
- Cited by
- 134
- References
- 34
- Citations by year
- 2025: 2 · 2024: 2 · 2023: 3 · 2022: 3 · 2021: 4 · 2020: 4 · 2019: 6 · 2018: 7 · 2017: 5 · 2016: 6 · 2015: 8 · 2014: 9 · 2013: 6 · 2012: 7
- FWCI
- 3.23
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Funders
- Johnson and Johnson
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Keywords
- central hypothyroidism, levothyroxine replacement therapy, treatment adequacy, free thyroxine, free triiodothyronine, thyroid-stimulating hormone, thyroid hormone action, soluble interleukin-2 receptor, overtreatment, undertreatment, dose adjustment
- MeSH terms
- Adult, Evaluation Studies as Topic, Female, Humans, Hypothyroidism, Male, Middle Aged, Prospective Studies, Thyroid Hormones, Thyroxine, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.